Q3 2019 Laboratory Corporation of America Holdings Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2019 LabCorp Holdings Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
(Operator Instructions) I would now like to hand the conference over to your speaker, Clarissa Willett, VP of Investor Relations. Please, go ahead.
Good morning, and welcome to LabCorp's Third Quarter 2019 Conference Call. As detailed in today's press release, there will be a replay of this conference call available via telephone and Internet.
With me today are Dave King, Chairman and Chief Executive Officer; Glenn Eisenberg, Executive Vice President and Chief Financial Officer; and John Ratliff, CEO of Covance Drug Development.
This morning, in the Investor Relations section of our website at www.labcorp.com, we posted both our press release and an Investor Relations' presentation with additional
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |